HIV Prevention

A type III hybrid effectiveness–implementation trial compared community-based organization versus direct-to-consumer delivery of the Keep It Up! digital HIV prevention intervention for young men who have...

A large US cohort study evaluated the scale, patient characteristics, and retention outcomes of telemedicine-delivered HIV preexposure prophylaxis (PrEP), offering clinicians new data on how telePrEP is...

Start fast, suppress durably, and think beyond the viral load: this primary care–focused guide covers diagnosis, same-day antiretroviral therapy, monitoring, opportunistic infection prevention, vaccines,...

A pilot randomized trial found that offering immediate pre-exposure prophylaxis (PrEP) initiation with a 28-day starter pack in the emergency department did not improve PrEP use or retention compared with...

In a recent multicenter retrospective case series, isotretinoin was effective in treating acne among transgender and gender-diverse individuals undergoing masculinizing hormone therapy, with significantly...

Sexual and gender minority (SGM) populations face significantly higher odds of being diagnosed with multiple mental health conditions compared with their cisgender heterosexual counterparts, according to a...

A large U.S. study found reduced HIV rates and better viral suppression among trans adults receiving hormone therapy in primary care settings.

In a diverse cohort of virologically suppressed women with HIV, long-acting cabotegravir and rilpivirine (CAB+RPV LA) maintained high rates of viral suppression with low virologic failure over a median...

Pre-exposure prophylaxis (PrEP) adherence continues to be one of the main challenges for the elimination of HIV transmission. Researchers tested the use of an automated directly observed therapy...

In a recent study, researchers examined the effectiveness of text messaging to support the use of pre-exposure prophylaxis use in certain patient populations who are at high-risk of HIV infection.